Haemonetics Corporation Depreciation
Haemonetics Corporation (HAE) reported Depreciation of $15.40 million for the 3-month period ending 2026-06-27, per its 10-Q filed 2026-08-06.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-08-06
- Haemonetics Corporation depreciation for the quarter ending 2026-06-27 was $15.40M, a 0.00% change year-over-year.
- Haemonetics Corporation depreciation for the quarter ending 2026-03-28 was $15.30M, a 0.66% increase year-over-year.
- Haemonetics Corporation depreciation for the quarter ending 2025-12-27 was $14.90M, a 1.97% decline year-over-year.
- Haemonetics Corporation depreciation for the quarter ending 2025-09-27 was $15.50M, a 3.33% increase year-over-year.
- Haemonetics Corporation depreciation for fiscal 2026 was $61.20M, a 2.00% increase from fiscal 2025.
- Haemonetics Corporation depreciation for fiscal 2025 was $60.00M, a 7.53% increase from fiscal 2024.
- Haemonetics Corporation depreciation for fiscal 2024 was $55.80M, a 8.98% increase from fiscal 2023.
- Haemonetics Corporation depreciation for fiscal 2023 was $51.20M, a 15.32% increase from fiscal 2022.
| Period end | Depreciation 3 month | Depreciation 6 month | Depreciation 9 month | Depreciation 12 month | Depreciation 12 month as first filed |
|---|---|---|---|---|---|
| 2026-06-27 | $15.40M 10-Q · filed 2026-08-06 | $30.70M derived: sum of 2 quarters · filed 2026-08-06 | $45.60M derived: sum of 3 quarters · filed 2026-08-06 | $61.10M derived: sum of 4 quarters · filed 2026-08-06 | |
| 2026-03-28 | $15.30M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $30.20M derived: sum of 2 quarters · filed 2026-05-20 | $45.70M derived: sum of 3 quarters · filed 2026-05-20 | $61.20M 10-K · filed 2026-05-20 | |
| 2025-12-27 | $14.90M 10-Q · filed 2026-02-05 | $30.40M derived: sum of 2 quarters · filed 2026-02-05 | $45.90M 10-Q · filed 2026-02-05 | $61.00M derived: sum of 4 quarters · filed 2026-05-20 | |
| 2025-09-27 | $15.50M 10-Q · filed 2025-11-06 | $30.90M 10-Q · filed 2025-11-06 | $46.10M derived: sum of 3 quarters · filed 2026-05-20 | $61.30M derived: sum of 4 quarters · filed 2026-05-20 | |
| 2025-06-28 | $15.40M 10-Q · filed 2025-08-07 | $30.60M derived: sum of 2 quarters · filed 2026-05-20 | $45.80M derived: sum of 3 quarters · filed 2026-05-20 | $60.80M derived: sum of 4 quarters · filed 2026-05-20 | |
| 2025-03-29 | $15.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $30.40M derived: sum of 2 quarters · filed 2026-05-20 | $45.40M derived: sum of 3 quarters · filed 2026-05-20 | $60.00M 10-K · filed 2026-05-20 | |
| 2024-12-28 | $15.20M 10-Q · filed 2026-02-05 | $30.20M derived: sum of 2 quarters · filed 2026-02-05 | $44.80M 10-Q · filed 2026-02-05 | $59.50M derived: sum of 4 quarters · filed 2026-05-20 | |
| 2024-09-28 | $15.00M 10-Q · filed 2025-11-06 | $29.60M 10-Q · filed 2025-11-06 | $44.30M derived: sum of 3 quarters · filed 2026-05-20 | $58.50M derived: sum of 4 quarters · filed 2026-05-20 | |
| 2024-06-29 | $14.60M 10-Q · filed 2025-08-07 | $29.30M derived: sum of 2 quarters · filed 2026-05-20 | $43.50M derived: sum of 3 quarters · filed 2026-05-20 | $57.10M derived: sum of 4 quarters · filed 2026-05-20 | |
| 2024-03-30 | $14.70M derived: 10-K 12 month − 10-Q 9 month · filed 2026-05-20 | $28.90M derived: sum of 2 quarters · filed 2026-05-20 | $42.50M derived: sum of 3 quarters · filed 2026-05-20 | $55.80M 10-K · filed 2026-05-20 | |
| 2023-12-30 | $14.20M 10-Q · filed 2025-02-06 | $27.80M derived: sum of 2 quarters · filed 2025-02-06 | $41.10M 10-Q · filed 2025-02-06 | $54.60M derived: sum of 4 quarters · filed 2025-05-21 | |
| 2023-09-30 | $13.60M 10-Q · filed 2024-11-07 | $26.90M 10-Q · filed 2024-11-07 | $40.40M derived: sum of 3 quarters · filed 2025-05-21 | $53.50M derived: sum of 4 quarters · filed 2025-05-21 | |
| 2023-07-01 | $13.30M 10-Q · filed 2024-08-08 | $26.80M derived: sum of 2 quarters · filed 2025-05-21 | $39.90M derived: sum of 3 quarters · filed 2025-05-21 | $52.80M derived: sum of 4 quarters · filed 2025-05-21 | |
| 2023-04-01 | $13.50M derived: 10-K 12 month − 10-Q 9 month · filed 2025-05-21 | $26.60M derived: sum of 2 quarters · filed 2025-05-21 | $39.50M derived: sum of 3 quarters · filed 2025-05-21 | $51.20M 10-K · filed 2025-05-21 | |
| 2022-12-31 | $13.10M 10-Q · filed 2024-02-08 | $26.00M derived: sum of 2 quarters · filed 2024-02-08 | $37.70M 10-Q · filed 2024-02-08 | ||
| 2022-10-01 | $12.90M 10-Q · filed 2023-11-02 | $24.60M 10-Q · filed 2023-11-02 | |||
| 2022-07-02 | $11.70M 10-Q · filed 2023-08-08 | ||||
| 2022-04-02 | $44.40M 10-K · filed 2024-05-20 | ||||
| 2021-04-03 | $43.10M 10-K · filed 2023-05-22 | ||||
| 2020-03-28 | $76.60M 10-K · filed 2022-05-25 | ||||
| 2019-03-30 | $76.80M 10-K · filed 2021-05-26 | ||||
| 2018-03-31 | $57.70M 10-K · filed 2020-05-20 | ||||
| 2017-04-01 | $66.50M 10-K · filed 2019-05-22 | ||||
| 2016-04-02 | $56.80M 10-K · filed 2018-05-23 | ||||
| 2015-03-28 | $52.60M 10-K · filed 2017-05-24 | ||||
| 2014-03-29 | $52.60M 10-K · filed 2016-06-01 | ||||
| 2013-03-30 | $43.40M 10-K · filed 2015-05-22 | ||||
| 2012-03-31 | $38.60M 10-K · filed 2014-05-22 | ||||
| 2011-04-02 | $36.80M 10-K · filed 2013-05-20 | $37.00M 10-K · filed 2012-05-22 | |||
| 2010-04-03 | $35.50M 10-K · filed 2012-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |